BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cvetkovic-Lopes V, Bayer L, Dorsaz S, Maret S, Pradervand S, Dauvilliers Y, Lecendreux M, Lammers GJ, Donjacour CE, Du Pasquier RA, Pfister C, Petit B, Hor H, Mühlethaler M, Tafti M. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J Clin Invest 2010;120:713-9. [PMID: 20160349 DOI: 10.1172/JCI41366] [Cited by in Crossref: 215] [Cited by in F6Publishing: 77] [Article Influence: 17.9] [Reference Citation Analysis]
Number Citing Articles
1 Sadam H, Pihlak A, Kivil A, Pihelgas S, Jaago M, Adler P, Vilo J, Vapalahti O, Neuman T, Lindholm D, Partinen M, Vaheri A, Palm K. Prostaglandin D2 Receptor DP1 Antibodies Predict Vaccine-induced and Spontaneous Narcolepsy Type 1: Large-scale Study of Antibody Profiling. EBioMedicine 2018;29:47-59. [PMID: 29449194 DOI: 10.1016/j.ebiom.2018.01.043] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
2 Kawashima M, Lin L, Tanaka S, Jennum P, Knudsen S, Nevsimalova S, Plazzi G, Mignot E. Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy. Sleep 2010;33:869-74. [PMID: 20614846 DOI: 10.1093/sleep/33.7.869] [Cited by in Crossref: 89] [Cited by in F6Publishing: 79] [Article Influence: 7.4] [Reference Citation Analysis]
3 Giannoccaro MP, Sallemi G, Liguori R, Plazzi G, Pizza F. Immunotherapy in Narcolepsy. Curr Treat Options Neurol 2020;22:2. [PMID: 31997035 DOI: 10.1007/s11940-020-0609-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lecendreux M, Churlaud G, Pitoiset F, Regnault A, Tran TA, Liblau R, Klatzmann D, Rosenzwajg M. Narcolepsy Type 1 Is Associated with a Systemic Increase and Activation of Regulatory T Cells and with a Systemic Activation of Global T Cells. PLoS One 2017;12:e0169836. [PMID: 28107375 DOI: 10.1371/journal.pone.0169836] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
5 Burgess CR, Scammell TE. Narcolepsy: neural mechanisms of sleepiness and cataplexy. J Neurosci 2012;32:12305-11. [PMID: 22956821 DOI: 10.1523/JNEUROSCI.2630-12.2012] [Cited by in Crossref: 82] [Cited by in F6Publishing: 35] [Article Influence: 8.2] [Reference Citation Analysis]
6 Dauvilliers Y, Montplaisir J, Cochen V, Desautels A, Einen M, Lin L, Kawashima M, Bayard S, Monaca C, Tiberge M, Filipini D, Tripathy A, Nguyen BH, Kotagal S, Mignot E. Post-H1N1 narcolepsy-cataplexy. Sleep 2010;33:1428-30. [PMID: 21102981 DOI: 10.1093/sleep/33.11.1428] [Cited by in Crossref: 150] [Cited by in F6Publishing: 115] [Article Influence: 13.6] [Reference Citation Analysis]
7 Melén K, Jalkanen P, Kukkonen JP, Partinen M, Nohynek H, Vuorela A, Vaarala O, Freitag TL, Meri S, Julkunen I. No evidence of autoimmunity to human OX1 or OX2 orexin receptors in Pandemrix-vaccinated narcoleptic children. J Transl Autoimmun 2020;3:100055. [PMID: 32743535 DOI: 10.1016/j.jtauto.2020.100055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Chin J, Bearison C, Silverberg N, Lee Wong M. Concomitant atopic dermatitis and narcolepsy type 1: psychiatric implications and challenges in management. Gen Psychiatr 2019;32:e100094. [PMID: 31673678 DOI: 10.1136/gpsych-2019-100094] [Reference Citation Analysis]
9 Akintomide GS, Rickards H. Narcolepsy: a review. Neuropsychiatr Dis Treat 2011;7:507-18. [PMID: 21931493 DOI: 10.2147/NDT.S23624] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
10 Mayer G, Bassetti CL, Dauvilliers Y. Treatment options in narcolepsy. Expert Opinion on Orphan Drugs 2013;1:987-99. [DOI: 10.1517/21678707.2013.854701] [Reference Citation Analysis]
11 Natarajan N, Jain SV, Chaudhry H, Hallinan BE, Simakajornboon N. Narcolepsy-cataplexy: is streptococcal infection a trigger? J Clin Sleep Med 2013;9:269-70. [PMID: 23493659 DOI: 10.5664/jcsm.2498] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
12 Lim AS, Scammell TE. The trouble with Tribbles: do antibodies against TRIB2 cause narcolepsy? Sleep 2010;33:857-8. [PMID: 20614841 DOI: 10.1093/sleep/33.7.857] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
13 Toyoda H, Tanaka S, Miyagawa T, Honda Y, Tokunaga K, Honda M. Anti-Tribbles homolog 2 autoantibodies in Japanese patients with narcolepsy. Sleep 2010;33:875-8. [PMID: 20614847 DOI: 10.1093/sleep/33.7.875] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 5.1] [Reference Citation Analysis]
14 Bergman P, Adori C, Vas S, Kai-Larsen Y, Sarkanen T, Cederlund A, Agerberth B, Julkunen I, Horvath B, Kostyalik D, Kalmár L, Bagdy G, Huutoniemi A, Partinen M, Hökfelt T. Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns. Proc Natl Acad Sci U S A 2014;111:E3735-44. [PMID: 25136085 DOI: 10.1073/pnas.1412189111] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 7.4] [Reference Citation Analysis]
15 Mahlios J, De la Herrán-Arita AK, Mignot E. The autoimmune basis of narcolepsy. Curr Opin Neurobiol 2013;23:767-73. [PMID: 23725858 DOI: 10.1016/j.conb.2013.04.013] [Cited by in Crossref: 110] [Cited by in F6Publishing: 84] [Article Influence: 12.2] [Reference Citation Analysis]
16 Tisdale RK, Yamanaka A, Kilduff TS. Animal models of narcolepsy and the hypocretin/orexin system: Past, present, and future. Sleep 2021;44:zsaa278. [PMID: 33313880 DOI: 10.1093/sleep/zsaa278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Ton TG, Longstreth WT Jr, Koepsell TD. Environmental toxins and risk of narcolepsy among people with HLA DQB1*0602. Environ Res 2010;110:565-70. [PMID: 20519130 DOI: 10.1016/j.envres.2010.05.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
18 Hor H, Kutalik Z, Dauvilliers Y, Valsesia A, Lammers GJ, Donjacour CE, Iranzo A, Santamaria J, Peraita Adrados R, Vicario JL, Overeem S, Arnulf I, Theodorou I, Jennum P, Knudsen S, Bassetti C, Mathis J, Lecendreux M, Mayer G, Geisler P, Benetó A, Petit B, Pfister C, Bürki JV, Didelot G, Billiard M, Ercilla G, Verduijn W, Claas FH, Vollenweider P, Waeber G, Waterworth DM, Mooser V, Heinzer R, Beckmann JS, Bergmann S, Tafti M. Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat Genet 2010;42:786-9. [PMID: 20711174 DOI: 10.1038/ng.647] [Cited by in Crossref: 139] [Cited by in F6Publishing: 114] [Article Influence: 11.6] [Reference Citation Analysis]
19 Pusch E, Renz H, Skevaki C. Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution? Allergo J Int 2018;27:79-96. [PMID: 32226720 DOI: 10.1007/s40629-018-0056-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
20 Liblau RS. Put to sleep by immune cells. Nature 2018;562:46-8. [PMID: 30275550 DOI: 10.1038/d41586-018-06666-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
21 Wasling P, Malmeström C, Blennow K. CSF orexin-A levels after rituximab treatment in recent onset narcolepsy type 1. Neurol Neuroimmunol Neuroinflamm 2019;6:e613. [PMID: 31484686 DOI: 10.1212/NXI.0000000000000613] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
22 Martinez-Martinez P, Molenaar PC, Losen M, Stevens J, Baets MH, Szoke A, Honnorat J, Tamouza R, Leboyer M, Os JV, Rutten BP. Autoantibodies to neurotransmitter receptors and ion channels: from neuromuscular to neuropsychiatric disorders. Front Genet 2013;4:181. [PMID: 24065983 DOI: 10.3389/fgene.2013.00181] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
23 Pedersen NW, Holm A, Kristensen NP, Bjerregaard AM, Bentzen AK, Marquard AM, Tamhane T, Burgdorf KS, Ullum H, Jennum P, Knudsen S, Hadrup SR, Kornum BR. CD8+ T cells from patients with narcolepsy and healthy controls recognize hypocretin neuron-specific antigens. Nat Commun 2019;10:837. [PMID: 30783092 DOI: 10.1038/s41467-019-08774-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 14.3] [Reference Citation Analysis]
24 Dale NC, Hoyer D, Jacobson LH, Pfleger KDG, Johnstone EKM. Orexin Signaling: A Complex, Multifaceted Process. Front Cell Neurosci 2022;16:812359. [DOI: 10.3389/fncel.2022.812359] [Reference Citation Analysis]
25 Latorre D, Federica S, Bassetti CLA, Kallweit U. Narcolepsy: a model interaction between immune system, nervous system, and sleep-wake regulation. Semin Immunopathol 2022. [PMID: 35445831 DOI: 10.1007/s00281-022-00933-9] [Reference Citation Analysis]
26 Couvineau A, Voisin T, Nicole P, Gratio V, Abad C, Tan YV. Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases. Front Endocrinol (Lausanne) 2019;10:709. [PMID: 31695678 DOI: 10.3389/fendo.2019.00709] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
27 Azzam S, Schlatzer D, Nethery D, Saleh D, Li X, Akladious A, Chance MR, Strohl KP. Proteomic profiling of the hypothalamus in two mouse models of narcolepsy. Proteomics 2017;17. [PMID: 28544614 DOI: 10.1002/pmic.201600478] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
28 van der Most R, Van Mechelen M, Destexhe E, Wettendorff M, Hanon E. Narcolepsy and A(H1N1)pdm09 vaccination: shaping the research on the observed signal. Hum Vaccin Immunother 2014;10:572-6. [PMID: 24342916 DOI: 10.4161/hv.27412] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
29 Lutterotti A. Is it Time for Immunotherapy Trials in Narcolepsy? J Clin Sleep Med 2017;13:363-4. [PMID: 28212698 DOI: 10.5664/jcsm.6478] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
30 Jiang W, Birtley JR, Hung SC, Wang W, Chiou SH, Macaubas C, Kornum B, Tian L, Huang H, Adler L, Weaver G, Lu L, Ilstad-Minnihan A, Somasundaram S, Ayyangar S, Davis MM, Stern LJ, Mellins ED. In vivo clonal expansion and phenotypes of hypocretin-specific CD4+ T cells in narcolepsy patients and controls. Nat Commun 2019;10:5247. [PMID: 31748512 DOI: 10.1038/s41467-019-13234-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
31 Bernard-Valnet R, Yshii L, Quériault C, Nguyen XH, Arthaud S, Rodrigues M, Canivet A, Morel AL, Matthys A, Bauer J, Pignolet B, Dauvilliers Y, Peyron C, Liblau RS. CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice. Proc Natl Acad Sci U S A 2016;113:10956-61. [PMID: 27621438 DOI: 10.1073/pnas.1603325113] [Cited by in Crossref: 73] [Cited by in F6Publishing: 62] [Article Influence: 12.2] [Reference Citation Analysis]
32 Yamasaki M, Miyagawa T, Toyoda H, Khor SS, Koike A, Nitta A, Akiyama K, Sasaki T, Honda Y, Honda M, Tokunaga K. Genome-wide analysis of CNV (copy number variation) and their associations with narcolepsy in a Japanese population. J Hum Genet 2014;59:235-40. [PMID: 24694762 DOI: 10.1038/jhg.2014.13] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
33 Lecendreux M, Berthier J, Corny J, Bourdon O, Dossier C, Delclaux C. Intravenous Immunoglobulin Therapy in Pediatric Narcolepsy: A Nonrandomized, Open-Label, Controlled, Longitudinal Observational Study. J Clin Sleep Med 2017;13:441-53. [PMID: 28095967 DOI: 10.5664/jcsm.6500] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
34 De la Herrán-arita AK, Drucker-colín R. Models for narcolepsy with cataplexy drug discovery. Expert Opinion on Drug Discovery 2012;7:155-64. [DOI: 10.1517/17460441.2012.651454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Carlander B, Puech-Cathala AM, Jaussent I, Scholz S, Bayard S, Cochen V, Dauvilliers Y. Low vitamin D in narcolepsy with cataplexy. PLoS One 2011;6:e20433. [PMID: 21633708 DOI: 10.1371/journal.pone.0020433] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
36 Kornum BR, Kawashima M, Faraco J, Lin L, Rico TJ, Hesselson S, Axtell RC, Kuipers H, Weiner K, Hamacher A, Kassack MU, Han F, Knudsen S, Li J, Dong X, Winkelmann J, Plazzi G, Nevsimalova S, Hong SC, Honda Y, Honda M, Högl B, Ton TG, Montplaisir J, Bourgin P, Kemlink D, Huang YS, Warby S, Einen M, Eshragh JL, Miyagawa T, Desautels A, Ruppert E, Hesla PE, Poli F, Pizza F, Frauscher B, Jeong JH, Lee SP, Strohl KP, Longstreth WT Jr, Kvale M, Dobrovolna M, Ohayon MM, Nepom GT, Wichmann HE, Rouleau GA, Gieger C, Levinson DF, Gejman PV, Meitinger T, Peppard P, Young T, Jennum P, Steinman L, Tokunaga K, Kwok PY, Risch N, Hallmayer J, Mignot E. Common variants in P2RY11 are associated with narcolepsy. Nat Genet 2011;43:66-71. [PMID: 21170044 DOI: 10.1038/ng.734] [Cited by in Crossref: 165] [Cited by in F6Publishing: 145] [Article Influence: 13.8] [Reference Citation Analysis]
37 Larson-Prior LJ, Ju YE, Galvin JE. Cortical-subcortical interactions in hypersomnia disorders: mechanisms underlying cognitive and behavioral aspects of the sleep-wake cycle. Front Neurol 2014;5:165. [PMID: 25309500 DOI: 10.3389/fneur.2014.00165] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
38 Ollila HM, Utge S, Kronholm E, Aho V, Van Leeuwen W, Silander K, Partonen T, Perola M, Kaprio J, Salomaa V, Sallinen M, Härmä M, Porkka-Heiskanen T, Paunio T. TRIB1 constitutes a molecular link between regulation of sleep and lipid metabolism in humans. Transl Psychiatry 2012;2:e97. [PMID: 22832862 DOI: 10.1038/tp.2012.20] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
39 Mahoney CE, Cogswell A, Koralnik IJ, Scammell TE. The neurobiological basis of narcolepsy. Nat Rev Neurosci 2019;20:83-93. [PMID: 30546103 DOI: 10.1038/s41583-018-0097-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 18.7] [Reference Citation Analysis]
40 Liu J, Merkle FT, Gandhi AV, Gagnon JA, Woods IG, Chiu CN, Shimogori T, Schier AF, Prober DA. Evolutionarily conserved regulation of hypocretin neuron specification by Lhx9. Development 2015;142:1113-24. [PMID: 25725064 DOI: 10.1242/dev.117424] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
41 Partinen M, Saarenpää-Heikkilä O, Ilveskoski I, Hublin C, Linna M, Olsén P, Nokelainen P, Alén R, Wallden T, Espo M, Rusanen H, Olme J, Sätilä H, Arikka H, Kaipainen P, Julkunen I, Kirjavainen T. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One 2012;7:e33723. [PMID: 22470463 DOI: 10.1371/journal.pone.0033723] [Cited by in Crossref: 295] [Cited by in F6Publishing: 232] [Article Influence: 29.5] [Reference Citation Analysis]
42 Inocente CO, Gustin MP, Lavault S, Guignard-Perret A, Raoux A, Christol N, Gerard D, Dauvilliers Y, Reimão R, Bat-Pitault F, Lin JS, Arnulf I, Lecendreux M, Franco P. Quality of life in children with narcolepsy. CNS Neurosci Ther 2014;20:763-71. [PMID: 24922610 DOI: 10.1111/cns.12291] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
43 Deloumeau A, Bayard S, Coquerel Q, Déchelotte P, Bole-Feysot C, Carlander B, Cochen De Cock V, Fetissov SO, Dauvilliers Y. Increased immune complexes of hypocretin autoantibodies in narcolepsy. PLoS One 2010;5:e13320. [PMID: 20967199 DOI: 10.1371/journal.pone.0013320] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
44 Sarkanen T, Alakuijala A, Julkunen I, Partinen M. Narcolepsy Associated with Pandemrix Vaccine. Curr Neurol Neurosci Rep 2018;18:43. [PMID: 29855798 DOI: 10.1007/s11910-018-0851-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
45 Sunwoo J. Narcolepsy, autoimmunity, and influenza A H1N1 vaccination. encephalitis 2021;1:31-5. [DOI: 10.47936/encephalitis.2021.00010] [Reference Citation Analysis]
46 Singh AK, Mahlios J, Mignot E. Genetic association, seasonal infections and autoimmune basis of narcolepsy. J Autoimmun 2013;43:26-31. [PMID: 23497937 DOI: 10.1016/j.jaut.2013.02.003] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 7.3] [Reference Citation Analysis]
47 Harbison ST, McCoy LJ, Mackay TF. Genome-wide association study of sleep in Drosophila melanogaster. BMC Genomics 2013;14:281. [PMID: 23617951 DOI: 10.1186/1471-2164-14-281] [Cited by in Crossref: 99] [Cited by in F6Publishing: 75] [Article Influence: 11.0] [Reference Citation Analysis]
48 Han F, Lin L, Li J, Aran A, Dong SX, An P, Zhao L, Li QY, Yan H, Wang JS, Gao HY, Li M, Gao ZC, Strohl KP, Mignot E. TCRA, P2RY11, and CPT1B/CHKB associations in Chinese narcolepsy. Sleep Med 2012;13:269-72. [PMID: 22177342 DOI: 10.1016/j.sleep.2011.06.020] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
49 Kumar S, Sagili H. Etiopathogenesis and neurobiology of narcolepsy: a review. J Clin Diagn Res 2014;8:190-5. [PMID: 24701532 DOI: 10.7860/JCDR/2014/7295.4057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
50 Martinez-Orozco FJ, Vicario JL, De Andres C, Fernandez-Arquero M, Peraita-Adrados R. Comorbidity of Narcolepsy Type 1 With Autoimmune Diseases and Other Immunopathological Disorders: A Case-Control Study. J Clin Med Res 2016;8:495-505. [PMID: 27298657 DOI: 10.14740/jocmr2569w] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
51 Pintwala SK, Peever J. Brain Circuits Underlying Narcolepsy. Neuroscientist 2021;:10738584211052263. [PMID: 34704497 DOI: 10.1177/10738584211052263] [Reference Citation Analysis]
52 Gao XB, Horvath TL. From molecule to behavior: hypocretin/orexin revisited from a sex-dependent perspective. Endocr Rev 2021:bnab042. [PMID: 34792130 DOI: 10.1210/endrev/bnab042] [Reference Citation Analysis]
53 Wozniak DR, Quinnell TG. Unmet needs of patients with narcolepsy: perspectives on emerging treatment options. Nat Sci Sleep 2015;7:51-61. [PMID: 26045680 DOI: 10.2147/NSS.S56077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
54 Hor H, Bartesaghi L, Kutalik Z, Vicário JL, de Andrés C, Pfister C, Lammers GJ, Guex N, Chrast R, Tafti M, Peraita-Adrados R. A missense mutation in myelin oligodendrocyte glycoprotein as a cause of familial narcolepsy with cataplexy. Am J Hum Genet 2011;89:474-9. [PMID: 21907016 DOI: 10.1016/j.ajhg.2011.08.007] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
55 Zhang M, Inocente CO, Villanueva C, Lecendreux M, Dauvilliers Y, Lin JS, Arnulf I, Gustin MP, Thieux M, Franco P. Narcolepsy with cataplexy: Does age at diagnosis change the clinical picture? CNS Neurosci Ther 2020. [PMID: 32761857 DOI: 10.1111/cns.13438] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
56 Aran A, Einen M, Lin L, Plazzi G, Nishino S, Mignot E. Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children. Sleep 2010;33:1457-64. [PMID: 21102987 DOI: 10.1093/sleep/33.11.1457] [Cited by in Crossref: 129] [Cited by in F6Publishing: 102] [Article Influence: 11.7] [Reference Citation Analysis]
57 Dalal J, Roh JH, Maloney SE, Akuffo A, Shah S, Yuan H, Wamsley B, Jones WB, de Guzman Strong C, Gray PA, Holtzman DM, Heintz N, Dougherty JD. Translational profiling of hypocretin neurons identifies candidate molecules for sleep regulation. Genes Dev 2013;27:565-78. [PMID: 23431030 DOI: 10.1101/gad.207654.112] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 7.6] [Reference Citation Analysis]
58 Giannoccaro MP, Liguori R, Plazzi G, Pizza F. Reviewing the Clinical Implications of Treating Narcolepsy as an Autoimmune Disorder. Nat Sci Sleep 2021;13:557-77. [PMID: 34007229 DOI: 10.2147/NSS.S275931] [Reference Citation Analysis]
59 Canellas F, Lin L, Julià MR, Clemente A, Vives-Bauza C, Ollila HM, Hong SC, Arboleya SM, Einen MA, Faraco J, Fernandez-Vina M, Mignot E. Dual cases of type 1 narcolepsy with schizophrenia and other psychotic disorders. J Clin Sleep Med 2014;10:1011-8. [PMID: 25142772 DOI: 10.5664/jcsm.4040] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
60 Miyagawa T, Tokunaga K. Genetics of narcolepsy. Hum Genome Var 2019;6:4. [PMID: 30652006 DOI: 10.1038/s41439-018-0033-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
61 Plazzi G, Pizza F, Palaia V, Franceschini C, Poli F, Moghadam KK, Cortelli P, Nobili L, Bruni O, Dauvilliers Y, Lin L, Edwards MJ, Mignot E, Bhatia KP. Complex movement disorders at disease onset in childhood narcolepsy with cataplexy. Brain 2011;134:3477-89. [PMID: 21930661 DOI: 10.1093/brain/awr244] [Cited by in Crossref: 103] [Cited by in F6Publishing: 90] [Article Influence: 9.4] [Reference Citation Analysis]
62 Magistri M, Khoury N, Mazza EM, Velmeshev D, Lee JK, Bicciato S, Tsoulfas P, Faghihi MA. A comparative transcriptomic analysis of astrocytes differentiation from human neural progenitor cells. Eur J Neurosci 2016;44:2858-70. [PMID: 27564458 DOI: 10.1111/ejn.13382] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
63 Luo G, Ambati A, Lin L, Bonvalet M, Partinen M, Ji X, Maecker HT, Mignot EJ. Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy. Proc Natl Acad Sci U S A 2018;115:E12323-32. [PMID: 30541895 DOI: 10.1073/pnas.1818150116] [Cited by in Crossref: 84] [Cited by in F6Publishing: 68] [Article Influence: 21.0] [Reference Citation Analysis]
64 Cunard R. Mammalian tribbles homologs at the crossroads of endoplasmic reticulum stress and Mammalian target of rapamycin pathways. Scientifica (Cairo) 2013;2013:750871. [PMID: 24490110 DOI: 10.1155/2013/750871] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
65 Saper CB, Fuller PM, Pedersen NP, Lu J, Scammell TE. Sleep state switching. Neuron 2010;68:1023-42. [PMID: 21172606 DOI: 10.1016/j.neuron.2010.11.032] [Cited by in Crossref: 775] [Cited by in F6Publishing: 639] [Article Influence: 70.5] [Reference Citation Analysis]
66 Inocente CO, Lavault S, Lecendreux M, Dauvilliers Y, Reimao R, Gustin MP, Castets S, Spiegel K, Lin JS, Arnulf I, Franco P. Impact of obesity in children with narcolepsy. CNS Neurosci Ther 2013;19:521-8. [PMID: 23574649 DOI: 10.1111/cns.12105] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
67 Song J, Kim E, Kim CH, Song HT, Lee JE. The role of orexin in post-stroke inflammation, cognitive decline, and depression. Mol Brain 2015;8:16. [PMID: 25884812 DOI: 10.1186/s13041-015-0106-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
68 Yelin-Bekerman L, Elbaz I, Diber A, Dahary D, Gibbs-Bar L, Alon S, Lerer-Goldshtein T, Appelbaum L. Hypocretin neuron-specific transcriptome profiling identifies the sleep modulator Kcnh4a. Elife 2015;4:e08638. [PMID: 26426478 DOI: 10.7554/eLife.08638] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
69 Seifinejad A, Li S, Mikhail C, Vassalli A, Pradervand S, Arribat Y, Pezeshgi Modarres H, Allen B, John RM, Amati F, Tafti M. Molecular codes and in vitro generation of hypocretin and melanin concentrating hormone neurons. Proc Natl Acad Sci U S A 2019;116:17061-70. [PMID: 31375626 DOI: 10.1073/pnas.1902148116] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
70 Bonvalet M, Ollila HM, Ambati A, Mignot E. Autoimmunity in narcolepsy. Curr Opin Pulm Med 2017;23:522-9. [PMID: 28991006 DOI: 10.1097/MCP.0000000000000426] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
71 Mignot EJ. History of narcolepsy at Stanford University. Immunol Res 2014;58:315-39. [PMID: 24825774 DOI: 10.1007/s12026-014-8513-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
72 Hartmann FJ, Bernard-Valnet R, Quériault C, Mrdjen D, Weber LM, Galli E, Krieg C, Robinson MD, Nguyen XH, Dauvilliers Y, Liblau RS, Becher B. High-dimensional single-cell analysis reveals the immune signature of narcolepsy. J Exp Med 2016;213:2621-33. [PMID: 27821550 DOI: 10.1084/jem.20160897] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 11.3] [Reference Citation Analysis]
73 Luo G, Yogeshwar S, Lin L, Mignot EJ. T cell reactivity to regulatory factor X4 in type 1 narcolepsy. Sci Rep 2021;11:7841. [PMID: 33837283 DOI: 10.1038/s41598-021-87481-8] [Reference Citation Analysis]
74 Shan L, Dauvilliers Y, Siegel JM. Interactions of the histamine and hypocretin systems in CNS disorders. Nat Rev Neurol 2015;11:401-13. [PMID: 26100750 DOI: 10.1038/nrneurol.2015.99] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 8.0] [Reference Citation Analysis]
75 Pizza F, Franceschini C, Peltola H, Vandi S, Finotti E, Ingravallo F, Nobili L, Bruni O, Lin L, Edwards MJ, Partinen M, Dauvilliers Y, Mignot E, Bhatia KP, Plazzi G. Clinical and polysomnographic course of childhood narcolepsy with cataplexy. Brain 2013;136:3787-95. [PMID: 24142146 DOI: 10.1093/brain/awt277] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 8.6] [Reference Citation Analysis]
76 Ramberger M, Högl B, Stefani A, Mitterling T, Reindl M, Lutterotti A. CD4+ T-Cell Reactivity to Orexin/Hypocretin in Patients With Narcolepsy Type 1. Sleep 2017;40. [PMID: 28364420 DOI: 10.1093/sleep/zsw070] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
77 Al Shareef SM, AlAnbay E, AlKhathlan MA, Shakoor Z, Alnasser M, Hamam KD, Alharbi AS, Almeneessier AS, BaHammam AS. HLA-DQB1*06:02 allele frequency and clinic-polysomnographic features in Saudi Arabian patients with narcolepsy. Sleep Breath 2019;23:303-9. [PMID: 30187366 DOI: 10.1007/s11325-018-1717-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
78 Luo G, Lin L, Jacob L, Bonvalet M, Ambati A, Plazzi G, Pizza F, Leib R, Adams CM, Partinen M, Mignot EJ. Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases. PLoS One 2017;12:e0187305. [PMID: 29220370 DOI: 10.1371/journal.pone.0187305] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
79 Pusch E, Renz H, Skevaki C. Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution? Allergo J 2018;27:28-45. [PMID: 32300267 DOI: 10.1007/s15007-018-1580-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
80 Blackburn KM, Wang C. Post-infectious neurological disorders. Ther Adv Neurol Disord 2020;13:1756286420952901. [PMID: 32944082 DOI: 10.1177/1756286420952901] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
81 Black SW, Yamanaka A, Kilduff TS. Challenges in the development of therapeutics for narcolepsy. Prog Neurobiol 2017;152:89-113. [PMID: 26721620 DOI: 10.1016/j.pneurobio.2015.12.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
82 Holm A, Bang-Berthelsen CH, Knudsen S, Kornum BR, Modvig S, Jennum P, Gammeltoft S. miRNA profiles in plasma from patients with sleep disorders reveal dysregulation of miRNAs in narcolepsy and other central hypersomnias. Sleep 2014;37:1525-33. [PMID: 25142559 DOI: 10.5665/sleep.4004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
83 Tafti M, Hor H, Dauvilliers Y, Lammers GJ, Overeem S, Mayer G, Javidi S, Iranzo A, Santamaria J, Peraita-Adrados R, Vicario JL, Arnulf I, Plazzi G, Bayard S, Poli F, Pizza F, Geisler P, Wierzbicka A, Bassetti CL, Mathis J, Lecendreux M, Donjacour CE, van der Heide A, Heinzer R, Haba-Rubio J, Feketeova E, Högl B, Frauscher B, Benetó A, Khatami R, Cañellas F, Pfister C, Scholz S, Billiard M, Baumann CR, Ercilla G, Verduijn W, Claas FH, Dubois V, Nowak J, Eberhard HP, Pradervand S, Hor CN, Testi M, Tiercy JM, Kutalik Z. DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. Sleep 2014;37:19-25. [PMID: 24381371 DOI: 10.5665/sleep.3300] [Cited by in Crossref: 118] [Cited by in F6Publishing: 103] [Article Influence: 14.8] [Reference Citation Analysis]
84 Mayer G. [Narcolepsy]. Nervenarzt 2014;85:26, 28-34. [PMID: 24408296 DOI: 10.1007/s00115-013-3889-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
85 Tafti M, Lammers GJ, Dauvilliers Y, Overeem S, Mayer G, Nowak J, Pfister C, Dubois V, Eliaou JF, Eberhard HP, Liblau R, Wierzbicka A, Geisler P, Bassetti CL, Mathis J, Lecendreux M, Khatami R, Heinzer R, Haba-Rubio J, Feketeova E, Baumann CR, Kutalik Z, Tiercy JM. Narcolepsy-Associated HLA Class I Alleles Implicate Cell-Mediated Cytotoxicity. Sleep 2016;39:581-7. [PMID: 26518595 DOI: 10.5665/sleep.5532] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 8.3] [Reference Citation Analysis]